Malte Peters is Chief Executive Officer of Tango Therapeutics, Inc. (TNGX). The company reported total compensation of $1,151,381 for fiscal year 2025.
| Salary | $148,315 |
|---|---|
| Bonus | $0 |
| Stock awards | $21,938 |
| Option awards | $981,128 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $1,151,381 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Tango Therapeutics, Inc. filed April 17, 2026, accession 0001193125-26-160287.
| Peer-group chief executive median | $5,414,805 |
|---|---|
| Difference from that median | $-4,263,424 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group Tango Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Barbara Weber | Former President and Chief Executive Officer (current Executive Chairman) | $2,823,992 |
| Adam Crystal | President of Research and Development | $1,721,080 |
| Daniella Beckman | Former Chief Financial Officer | $1,155,775 |
| Malte Peters this page | Chief Executive Officer | $1,151,381 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Tango Therapeutics, Inc. compensation brief.
Malte Peters's compensation sits inside Tango Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.